US Charges Google Engineer with Insider Trading on Polymarket Prediction Platform Barclays Reports 18 Profit Increase Raises Income Guidance Traders Eye IonQ Micron Anduril as Potential Next US Government Stakes After Quantum Company Investments BlockCon Punta Cana Announces Global Business Retreat for Web3 iGaming and Finance Convergence Retail Traders Outperform Professionals on Prediction Markets NYT Analysis Finds Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Bowman Consulting Group Ltd Q1 2026 Earnings Significant EPS Miss Pressures Stock WFC Q1 2026 Earnings Narrow EPS Beat Lifts Shares as Revenue Picture Remains Unclear YCBD Q1 2026 Earnings EPS Misses Estimates Stock Declines Oscar Health OSCR Q1 2026 Earnings EPS Smashes Estimates by 71 Shares Gain NCNA Q3 2024 Earnings Narrowed Loss Beats Expectations EMN Q1 2026 Earnings Earnings Beat on Lower Expectations Revenue Figures Not Disclosed ZOOZ Warrants Surge 5789 Analyzing the Sharp Move in ZOOZW Comstock Resources CRK Slides 12 as Energy Sector Headwinds Persist FreightCar America RAIL Edges Higher Amid Railroad Equipment Market Dynamics Liquidia Corporation LQDA Slips Amidst Market Caution Key Support Levels in Focus Proficient Auto Logistics PAL Holds Near Support After Slight Decline As AI Reshapes the Job Market Skilled Trade Workers May Gain Ground on College Graduates BWBBP Q1 2026 Earnings Preferred Stock EPS Slightly Misses Estimates Stock Declines Modestly Main Street Capital MAIN Climbs 052 Nearing Key Resistance Zone XNCR Q1 2026 Earnings Earnings Miss by Wide Margin as Losses Deepen Galaxy Digital GLXY Q1 2026 Earnings Crypto Volatility Weighs on Quarterly Results as EPS Falls Short PRS Q1 2026 Earnings Robust EPS Beat of 154 Highlights Operational Strength Amid Stable FixedIncome Performance OCSL Q1 2026 Earnings EPS Surpasses Estimates as Portfolio Remains Resilient NOK Q1 2026 Earnings EPS Surpasses Estimates by 2285 Shares Jump OCC Q1 2026 Earnings Net Loss of 005 Per Share Stock Climbs 788 SKYE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development